MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS Biotech Investing
NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology Biotech Investing
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia Biotech Investing
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD Pharmaceutical Investing
Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid Pharmaceutical Investing
Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Pharmaceutical Investing
